FHACT® takes the guess work out of cervical cancer screening

WATCH THE VIDEO >

Get answers,
get FHACT®.
Webinar series.

LEARN MORE >

FHACT® is indicated for HPV-positive ASCUS and LSIL patients.

LEARN MORE >

FHACT® is the only FISH Probe to assess four biomarkers associated with cervical cancer.

Learn More

Latest News

16 Dec 14

Cancer Genetics, Inc. Announces Appointment of Venkatadri Bobba to Cancer Genetics India's Board of Directors (read more...)

- RUTHERFORD, N.J. and HYDERABAD, India, Dec. 16, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"), an emerging (read more...)
10 Dec 14

Cancer Genetics, Inc. Strengthens Clinical Trials Leadership Team With Hire of Rob Fannon as Vice President of Operations (read more...)

- RUTHERFORD, N.J. and RALEIGH, N.C., Dec. 10, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the Company"), an emerging (read more...)

Events

05 Jun 15

American Society for Colposcopy & Cervical Pathology

29 May 15

American Society of Clinical Oncology Annual Meeting

21 Mar 15

United States & Canadian Academy of Pathology

Clinicians
Patients